Overview
- A review in Ituri province reported on Monday added 314 earlier Ebola deaths, bringing official totals to about 10,414 confirmed infections and 5,372 deaths and raising the reported case‑fatality ratio to 51.6%.
- The outbreak began in May in eastern DRC and has grown into the country’s largest Ebola epidemic and the largest globally since 2013–2016, concentrated across multiple provinces and dozens of health zones.
- No vaccine or antiviral is licensed against the Bundibugyo strain, so regulators and researchers have opened trials of existing candidates such as Ervebo and the TUMAINI study to test cross‑protection, with clear results still months away.
- Response work is undercut by violence and mistrust, including an October 24 attack in Bafwasende that killed a nurse and closed a treatment site, widespread community deaths outside treatment centers, and gaps in contact tracing.
- Countries are tightening border measures and screening: the US CDC now requires travelers to attest they have not been in the DRC in the previous 21 days, Nigeria confirmed two suspected cases as negative after repeat testing, and neighboring states remain on alert for importations.